超声弹性成像与超声造影诊断肝脏占位性病变性质价值分析

doi:10.3969/j.issn.1672-5069.2018.04.039

Abstract

Li Cheng, Ma Qinfeng, Gao Li. Comparison of ultrasonic elastography and contrast enhanced ultrasonography in differential diagnosis of hepatic lesions[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(4): 631-632.

References

[1] 杜凌遥,唐红. 肝占位性病变的常见病因与临床表现.中华肝脏病杂志,2017,25(1):56-60.
[2] Maruyama H,Takahashi M,Ishibashi H,et al.Contrast-enhanced ultrasound for characterisation of hepatic lesions appearing non-hypervascular on CT in chronic liver diseases.Br J Radiol,2012,85(1012):351-357.
[3] Takahashi M,Maruyama H,Ishibashi H,et al.Contrast-enhanced ultrasound with perflubutane microbubble agent:evaluation of differentiation of hepatocellular carcinoma.AJR,2011,196(2):W123-131.
[4] Wu W,Chen MH,Sun M,et al.Contrast-enhanced ultrasound of hepatocarcinogenesis in liver cirrhosis. Chin Med J (Engl),2012,125(17):3104-3109.
[5] Yoshizumi H,Maruyama H,Okugawa H,et al.How to characterize non-hypervascular hepatic nodules on contrast-enhanced computed tomography in chronic liver disease:feasibility of contrast-enhanced ultrasound with a microbubble contrast agent. J Gastroenterol Hepatol,2008,23(10):1528-1534.
[6] Claudon M,Dietrich CF,Choi BI,et al.Guidelines and good clinical practice recommendations for contrast enhanced ultrasound CEUS in the liver-update 2012 a WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB AIUM ASUM FLAUS and ICUS. Ultrasound Med,2013,34(1):11-29.
[7] Numata K,Fukuda H,Nihonmatsu H,et al.Use of vessel patterns on contrast-enhanced ultrasonography using a perflubutane-based contrast agent for the differential diagnosis of regenerative nodules from early hepatocellular carcinoma or high-grade dysplastic nodules in patients with chronic liver disease.Abdom Imaging,2015,40(7):2372-2383.
[8] Beaton C,Cochlin D,Kumar N.Contrast enhanced ultrasound should be the initial radiological investigation to characterize focal liver lesions. Eur J Surg Oncol,2010,36(1):43-46.
[9] Maruyama H,Takahashi M,et al.Changes in tumor vascularity precede microbubble contrast accumulation deficit in the process of dedifferentiation of hepatocellular carcinoma. Eur J Radiol,2010,75(1):102-106.
[10] 王阁,李建.重视影像学检查在肝占位性病变鉴别诊断中的地位. 实用肝脏病杂志,2013,16(5):385-388.
[11] Hohmann J,Skrok J,et al.Characterization of focal liver lesions with contrast-enhanced low MI real time ultrasound and SonoVue.Rofo,2003,175(6):835-834.

[1]	National Workshop on Fatty Liver, Alcoholic Liver Disease, Chinese Society of Hepatology; National Workshop on Liver, Metabolism, Chinese Society of Endocrinology, Chinese Medical Association. Committee of Hepatology, Chinese Research Hospital Association; Fatty Liver Expert Committee, Chinese Medical Doctor Association [J]. Journal of Practical Hepatology, 2019, 22(6): 787-792.
[2]	. Consensus on the diagnosis and therapy of hepatic fibrosis [J]. Journal of Practical Hepatology, 2019, 22(6): 793-803.
[3]	Cao Ce, Yu Yixing, Wang Beibei, et al.. Clinical diagnostic efficacy of enhanced magnetic resonance imaging combined with serum AFP and PIVKA-Ⅱ in the diagnosis of patients with hepatocellular carcinoma [J]. Journal of Practical Hepatology, 2019, 22(6): 896-899.
[4]	Zeng Yanni, Zhang Can, Bi Junying, et al.. Value of long-time delayed enhancement scan of MRI in the diagnosis of solitary necrotic nodule of liver [J]. Journal of Practical Hepatology, 2019, 22(6): 900-903.
[5]	Xing Hao, Han Jun, Yang Tian.. Diagnostic value of serum protein induced by vitamin K absence or antagonist II for hepatocellular carcinoma [J]. Journal of Practical Hepatology, 2019, 22(6): 934-937.
[6]	Liang Jubo, Miao Qi, Ma Xiong.. Diagnosis and treatment of cholangiocytic cholestasis [J]. Journal of Practical Hepatology, 2019, 22(6): 941-943.
[7]	Gao Wei, Hou Yong. Diagnostic efficacy of hepatic fibrosis by liver stiffness measurement in patients with chronic hepatitis B [J]. Journal of Practical Hepatology, 2019, 22(5): 652-655.
[8]	Huang Hanjun, Lu Fengrong, Zhang Can. Clinical value of MRI scanning based on exchange hemodynamics model in evaluating liver cirrhosis [J]. Journal of Practical Hepatology, 2019, 22(5): 696-699.
[9]	Hong Jia, Wu Xiaoning, You Hong. Standardized diagnosis of cholestatic liver diseases [J]. Journal of Practical Hepatology, 2019, 22(5): 758-760.
[10]	Cheng Hua, Ju Hui, Song Deshun et al. Value of serum angiopoietin-like protein 2 and Golgi protein 73 levels in the diagnosis of hepatic fibrosis in patient with chronic hepatitis B [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 494-497.
[11]	Yu Yingfang, Wen Shengbao. Assessment of liver fibrosis with diffusion-weighted magnetic resonance imaging using single, double and stretch index model in patients with chronic hepatitis B [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 502-505.
[12]	Zhang Yafei, Ye Jun, Xie Qinxiu, et al. Difference in predicting efficacy of significant liver fibrosis by noninvasive liver fibrosis index in different hospitals [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 510-513.
[13]	Xie Xiao, Liu Ting, Dong Zhixia, et al. Value of controlled attenuation parameter in diagnosis of individuals with liver steatosis by using Fibrotouch [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 526-529.
[14]	Zhang Junfei, Xu Heming, Song Haiyan, et al. Autoimmune hepatitis-primary biliary cholangitis overlap syndrome:poor diagnostic sensitivity of Paris' criteria in Chinese patients [J]. Journal of Practical Hepatology, 2019, 22(4): 537-540.
[15]	Yang Fucun, Shang Huaixue, Gai Yonghao. Enhanced magnetic resonance imaging by gadolinium disodium sebacate in diagnosis of patients with focal liver lesions [J]. Journal of Practical Hepatology, 2019, 22(4): 577-580.

Comparison of ultrasonic elastography and contrast enhanced ultrasonography in differential diagnosis of hepatic lesions

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments